CD226 (DNAM-1) is constitutively expressed on native CD8+ cells and on some CD4+ T cells, macrophages and NK cells. CD226 is involved in NK and T cell mediated cytotoxicity against certain tumors. CD155 and CD112 are the ligands for CD226. This antibody (480.1) is reported by the developer to partially block the binding of mouse CD155.

PRODUCT DETAILS

Clone: 480.1

Antibody Type: Monoclonal

Reactivity: Mouse

Format: PE

Host: Rat

Isotype: IgG2a, κ

Applications: FC - Quality tested

Regulatory Status: RUO

Data Sheets: TDS | SDS

Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.